Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Intracoronary eptifibatide with vasodilators to prevent no-reflow in diabetic STEMI with high thrombus burden. A randomized trial

Mohamed Hamza,Islam Y Elgendy

Revista Española de Cardiología (English Edition)（2022）

Cited 0|Views2
No score
Abstract
Among diabetic patients with STEMI and high thrombus burden, intracoronary eptifibatide plus vasodilators injection was beneficial in preventing no-reflow compared with thrombus aspiration alone. Larger studies are encouraged to investigate the benefit of this strategy in reducing the risk of adverse clinical events.
More
Translated text
Key words
Thrombus aspiration,ST-elevation myocardial infarction,Primary percutaneous coronary intervention,Glycoprotein IIb/IIIa receptor inhibitor,No-reflow
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined